Vivici has launched Vivitein LF in the US, introducing a precision-fermented version of lactoferrin that aims to address longstanding supply and cost constraints.

Agronomics, the London-listed cellular agriculture investor, has put a further AUD 3 million (£1.5 million) into Australian biotech All G.

Australian biotech innovator All G has launched a joint venture with France-based bioactives company Armor Protéines, alongside the close of a $6.6m convertible note round.

TurtleTree has received a ‘No Questions’ letter from the US Food and Drug Administration, validating the safety of its precision-fermented lactoferrin ingredient for use in food.

Dutch ingredients start-up Vivici has raised €32.5 million in Series A funding to expand its precision fermentation dairy protein business.

This time, we speak to Jan Pacas, CEO and founder of Australian precision fermentation specialist All G.

TurtleTree has partnered with Mad Foods to enhance the brand’s oat milk coffee beverages with precision-fermented lactoferrin.

Melissa Bradshaw, editor of The Plant Base, explores the offerings available in the plant-based infant and toddler nutrition category.

US biotech start-up Helaina has raised $45 million in a Series B funding round led by investment firm Avidity Partners.

US precision fermentation specialist De Novo Foodlabs has announced an additional funding raise, bringing its total funding to $4 million.

Precision-fermented dairy company TurtleTree has entered into a new multi-year strategic partnership with Strive.